114
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece

, , , &
Pages 2251-2257 | Accepted 22 Jun 2007, Published online: 15 Aug 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Louise Raunkilde, Torben Frøstrup Hansen, Birgitte Mayland Havelund, Caroline Brenner Thomsen, Søren Rafael Rafaelsen, Jan Lindebjerg & Lars Henrik Jensen. (2023) Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study. Acta Oncologica 62:9, pages 1066-1075.
Read now
Nikos Maniadakis, Vasilios Fragoulakis, Dimitrios Pectasides & George Fountzilas. (2009) XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis. Current Medical Research and Opinion 25:3, pages 797-805.
Read now

Articles from other publishers (8)

K. R. Yabroff, L. Borowski & J. Lipscomb. (2013) Economic Studies in Colorectal Cancer: Challenges in Measuring and Comparing Costs. JNCI Monographs 2013:46, pages 62-78.
Crossref
Vassilis Fragoulakis, Vasilia Papagiannopoulou, Georgia Kourlaba, Nikolaos Maniadakis & Georgios Fountzilas. (2012) Cost-Minimization Analysis of the Treatment of Patients With Metastatic Colorectal Cancer in Greece. Clinical Therapeutics 34:10, pages 2132-2142.
Crossref
Georgia Kourlaba, Vassilis Fragoulakis & Nikos Maniadakis. (2012) Clopidogrel versus Aspirin in Patients with Atherothrombosis. Applied Health Economics and Health Policy 10:5, pages 331-342.
Crossref
Georgia Kourlaba, Vassilis Fragoulakis & Nikos Maniadakis. (2012) Clopidogrel versus Aspirin in Patients with Atherothrombosis. Applied Health Economics and Health Policy 10:5, pages 331-342.
Crossref
Georgia Kourlaba, Vassilis Fragoulakis & Nikos Maniadakis. (2012) Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece. Applied Health Economics and Health Policy 10:4, pages 261-271.
Crossref
N. Maniadakis, V. Fragoulakis, A.G. Pallis, E. Simou & V. Georgoulias. (2010) Economic evaluation of docetaxel–gemcitabine versus vinorelbine–cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis. Annals of Oncology 21:7, pages 1462-1467.
Crossref
N. Maniadakis, U. Dafni, V. Fragoulakis, I. Grimani, E. Galani, A. Fragkoulidi & G. Fountzilas. (2009) Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial. Annals of Oncology 20:2, pages 278-285.
Crossref
. (2013) FOLFIRI better value than FOLFOXIRI for metastatic CRC. PharmacoEconomics & Outcomes News 538:1, pages 4-4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.